Evinacumab(anti-ANGPTL3)
Evinacumab is a monoclonal antibody that targets, binds to, and pharmacologically inhibits ANGPTL3, which can act as a complementary agent to other LDL-C lowering regimens for patients aged 12 or older with HoFH.
| Catalog Number | A2049 |
| CAS# | 1446419-85-7 |
| Size | 1mg*25 |
| Supplier Page | http://www.selleckchem.com/products/evinacumab-anti-angptl3-.html |